当前位置: X-MOL 学术J. Clin. Periodontol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH
Journal of Clinical Periodontology ( IF 6.7 ) Pub Date : 2021-07-11 , DOI: 10.1111/jcpe.13523
Atsuhiro Nagasaki 1 , Shinnichi Sakamoto 1 , Toshiki Arai 1 , Minami Kato 1 , Eri Ishida 2 , Hisako Furusho 1 , Makiko Fujii 3 , Takashi Takata 1, 4 , Mutsumi Miyauchi 1
Affiliation  

Non-alcoholic steatohepatitis (NASH) is a critical liver disease showing potential progression to liver cirrhosis/cancer. Previously, we had reported that odontogenic infection of Porphyromonas gingivalis (P. gingivalis), a major periodontal pathogen, exacerbates fibrosis in NASH through the production of fibrosis mediators such as transforming growth factor-β1 (TGF-β1) and galectin-3. In this study, we determined the effects of therapeutic interventions using antibiotics on NASH progression induced by P. gingivalis odontogenic infection.

中文翻译:

消除牙龈卟啉单胞菌可抑制 NASH 中的肝纤维化和炎症

非酒精性脂肪性肝炎 (NASH) 是一种严重的肝脏疾病,有可能发展为肝硬化/癌症。此前,我们曾报道牙龈卟啉单胞菌P. gingivalis)的牙源性感染是一种主要的牙周病原体,通过产生转化生长因子-β1(TGF-β1)和半乳糖凝集素-3等纤维化介质,加剧了 NASH 中的纤维化。在这项研究中,我们确定了使用抗生素的治疗干预对牙龈卟啉单牙源性感染诱导的 NASH 进展的影响。
更新日期:2021-09-16
down
wechat
bug